Latest Information Update: 15 Apr 2004
At a glance
- Originator Sirus
- Class Analgesics; Nonsteroidal anti-inflammatories
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 11 Mar 2004 Discontinued - Preclinical for Pain in United Kingdom (Sublingual)
- 30 Jun 2003 Preclinical trials in Pain in United Kingdom (Sublingual)